{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:12:50Z","timestamp":1775020370027,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005758","name":"Universit\u00e0 Politecnica delle Marche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi and Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018429","name":"Istituto Europeo di Oncologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clbc.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T02:38:29Z","timestamp":1754620709000},"page":"782-791.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quality of life and Satisfaction With Ospemifene for Treating Vulvovaginal Atrophy in Breast Cancer Survivors: Six-Month Results From the PatiEnt SatisfactiON StudY (PEONY)"],"prefix":"10.1016","volume":"25","author":[{"given":"Paola","family":"Villa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Cassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella E.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina E.","family":"Bounous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorella","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Guida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inbal Dona","family":"Amar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Cova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Di Lelio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusi","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Trionfera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Meriggiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2025.08.001_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2025.08.001_bib0002","first-page":"2507","article-title":"Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: results of an Italian Delphi Panel","volume":"28","author":"Biglia","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clbc.2025.08.001_bib0003","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/GME.0000000000001260","article-title":"The burden of vulvovaginal atrophy on women\u2019s daily living: implications on quality of life from a face-to-face real-life survey","volume":"26","author":"Nappi","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2025.08.001_bib0004","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","article-title":"Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer","volume":"126","author":"Hershman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2025.08.001_bib0005","doi-asserted-by":"crossref","first-page":"qfae035","DOI":"10.1093\/sexmed\/qfae035","article-title":"Assessment of sexual function in postmenopausal breast cancer survivors","volume":"12","author":"Vitorino","year":"2024","journal-title":"Sex Med"},{"key":"10.1016\/j.clbc.2025.08.001_bib0006","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ajog.2015.03.039","article-title":"A manifesto on the preservation of sexual function in women and girls with cancer","volume":"213","author":"Lindau","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clbc.2025.08.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001500.pub3","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","author":"Lethaby","year":"2016","journal-title":"Cochrane Database Syst Rev [Internet]"},{"key":"10.1016\/j.clbc.2025.08.001_bib0008","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/GME.0000000000001121","article-title":"Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women\u2019s Sexual Health","volume":"25","author":"Faubion","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2025.08.001_bib0009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejogrb.2022.08.012","article-title":"Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: a valid therapeutic choice? A systematic review","volume":"277","author":"D'Oria","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.clbc.2025.08.001_bib0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/GME.0000000000001292","article-title":"Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial","volume":"26","author":"Archer","year":"2019","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.clbc.2025.08.001_bib0011","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/13697137.2023.2190881","article-title":"Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence","volume":"26","author":"Palacios","year":"2023","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2025.08.001_bib0012","first-page":"1","article-title":"Ospemifene for vulvar and vaginal atrophy: an overview","volume":"9","author":"Palacios","year":"2020","journal-title":"Drugs Context"},{"key":"10.1016\/j.clbc.2025.08.001_bib0013","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.maturitas.2020.06.021","article-title":"No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA)","volume":"142","author":"Cai","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2025.08.001_bib0014","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.maturitas.2018.11.017","article-title":"Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part II: evaluation of tolerability and safety","volume":"121","author":"Di Donato","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2025.08.001_bib0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/GME.0000000000000624","article-title":"Effects of ospemifene, a novel selective estrogen-receptor modulator, on human breast tissue ex vivo","volume":"23","author":"Eigeliene","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2025.08.001_bib0016","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.maturitas.2013.12.005","article-title":"Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women","volume":"77","author":"Simon","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2025.08.001_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2024.107950","article-title":"Vulvovaginal atrophy in women with and without a history of breast cancer: baseline data from the PatiEnt satisfactiON studY (PEONY) in Italy","volume":"183","author":"Meriggiola","year":"2024","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2025.08.001_bib0018","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0378-5122(95)00956-6","article-title":"Urogenital ageing: an old problem newly recognized","volume":"22","author":"Bachmann","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2025.08.001_bib0019","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/13697137.2018.1446930","article-title":"The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause","volume":"21","author":"Palacios","year":"2018","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.001_bib0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/09513590.2020.1813273","article-title":"The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy","volume":"37","author":"Nappi","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.clbc.2025.08.001_bib0021","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/13697137.2016.1262840","article-title":"Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions","volume":"20","author":"Palacios","year":"2017","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2025.08.001_bib0022","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/GME.0000000000000281","article-title":"Day-to-day impact of vaginal aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women","volume":"22","author":"Huang","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2025.08.001_bib0023","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1743-6109.2007.00672.x","article-title":"Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder","volume":"5","author":"DeRogatis","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.clbc.2025.08.001_bib0024","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.clbc.2025.08.001_bib0025","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0895-4356(98)00109-7","article-title":"Cross-validation of item selection and scoring for the SF-12 health survey in nine countries","volume":"51","author":"Gandek","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clbc.2025.08.001_bib0026","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/09513590.2022.2083103","article-title":"Long-term use of ospemifene in clinical practice for vulvo-vaginal atrophy: end results at 12 months of follow-up","volume":"38","author":"Pingarr\u00f3n Santof\u00edmia","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.clbc.2025.08.001_bib0027","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5122(03)00087-2","article-title":"Menopause after breast cancer: a survey on breast cancer survivors","volume":"45","author":"Biglia","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2025.08.001_bib0028","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.1998.16.2.501","article-title":"Life after breast cancer: understanding women\u2019s health-related quality of life and sexual functioning","volume":"16","author":"Ganz","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.08.001_bib0029","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2020.05.011","article-title":"Lower urinary tract symptoms and their relation to vaginal atrophy in women across the menopausal age span. Results from the ANGEL multicentre observational study","volume":"140","author":"Cagnacci","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2025.08.001_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s12905-021-01523-x","article-title":"As long as I have a restroom somewhere [\u2026], I am fine\u2019: a qualitative study on the perspectives of peri- and postmenopausal women on the impact of the urinary component of the genitourinary syndrome of menopause (GSM)","volume":"21","author":"Gabes","year":"2021","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.clbc.2025.08.001_bib0031","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/13697137.2023.2202811","article-title":"Urologic view in the management of genitourinary syndrome of menopause","volume":"26","author":"Wasserman","year":"2023","journal-title":"Climacteric"},{"issue":"8","key":"10.1016\/j.clbc.2025.08.001_bib0032","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/09513590.2018.1441398","article-title":"Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality?","volume":"34","author":"Schiavi","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.clbc.2025.08.001_bib0033","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/GRF.0000000000000847","article-title":"Genitourinary syndrome of menopause: prevalence and predictors","volume":"67","author":"Woods","year":"2024","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.clbc.2025.08.001_bib0034","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cncr.26324","article-title":"Urinary symptoms in breast cancer: a systematic review","volume":"118","author":"Donovan","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2025.08.001_bib0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2019.08.043","article-title":"Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy","volume":"222","author":"Crean-Tate","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clbc.2025.08.001_bib0036","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpobgyn.2021.11.006","article-title":"Sexuality, pelvic floor\/vaginal health and contraception at menopause","volume":"81","author":"Nappi","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.clbc.2025.08.001_bib0037","series-title":"Optimizing Breast Cancer Management","first-page":"167","article-title":"Sexual function post-breast cancer [Internet]","author":"Streicher","year":"2018"},{"key":"10.1016\/j.clbc.2025.08.001_bib0038","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/GME.0000000000000219","article-title":"Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis","volume":"21","author":"Davis","year":"2014","journal-title":"Menopause"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925002289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925002289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:55:52Z","timestamp":1766152552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820925002289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1526820925002289"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.08.001","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life and Satisfaction With Ospemifene for Treating Vulvovaginal Atrophy in Breast Cancer Survivors: Six-Month Results From the PatiEnt SatisfactiON StudY (PEONY)","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}